2008～2010年我院抗糖尿病用药情况分析  

The analysis of antidiabetic medicines usage in our hospital from 2008 to 2010

作　　者：赵世翔[1] 王江安 

机构地区：[1]镇江市疾病预防控制中心,镇江212002 [2]镇江市妇幼保健医院,镇江212003

出　　处：《西北药学杂志》2012年第5期480-481,共2页Northwest Pharmaceutical Journal

摘　　要：目的分析我院2008～2010年抗糖尿病药物的使用情况。方法对我院2008～2010年抗糖尿病药物的用药金额和用药频度进行统计分析。结果各类抗糖尿病药物销售额呈现逐年上升趋势,注射用胰岛素类制剂所占份额略高于口服类降糖药。在口服类降糖药中,二甲双胍、阿卡波糖、吡格列酮、格列美脲用药频度一直位列前4位。结论各类抗糖尿病药物销售额及用药频度相对稳定,提示我院抗糖尿病药物使用基本合理。Objective To analyze the usage of anti-diabetic medicines in our hospital from 2008 to 2010. Methods The anti-diabetic medicine＇s using amount and medication frequency in our hospital from 2008 to 2010 were analyzed statistically. Results The sale-room of various anti-diabetic medicines appeared a escalating trend. The injectable insulin＇s portion was slightly higher than the o-ral hypoglycemic agents. Between oral hypoglycemic agents, the usage of melbine, acarbose, pioglitazone and glimepiride ranked the top four position. Conclusion The saleroom and medication frequency of various anti-diabetic medicines are relatively steady. The results show the usage of anti-diabetic medicine in our hospital is generally reasonable.

关 键 词：抗糖尿病药物 用药金额 用药频度 

分 类 号：R969.9[医药卫生—药理学]